Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

GLP-1s: FDA issues warning over rare eye condition

BMJView source article

Part of story

FDA issues warning on GLP-1 drugs over rare eye condition causing sudden blindness

The FDA has added a warning to all GLP-1 agonist labels about a rare eye condition, nonarteritic anterior ischemic optic neuropathy, that could cause sudden permanent blindness.

Nov 17, 2026·2 sourcesGLP-1 receptor agonistsDrug safetyObesity treatmentFDA regulationDrug labeling & regulationGLP-1 / Weight-Loss MedicationsDrug Policy, Pricing & ApprovalNew York CityGLP-1 drug side effects
FDA issues warning on GLP-1 drugs over rare eye condition causing sudden blindness
00

Other sources for this story

Medscape

GLP-1s and Nonarteritic Anterior Ischemic Optic Neuropathy: What Clinicians Should Know